(Press-News.org) Breast cancer incidence declined among postmenopausal women in Canada as their use of hormone therapy declined, according to a study published online September 23 in The Journal of the National Cancer Institute.
The Women's Health Initiative (WHI) trial of more than 16,000 postmenopausal women in the United States reported in 2002 that the risks of combined estrogen and progestin hormone replacement therapy outweighed the benefits. As a result, prescriptions for hormone therapy fell dramatically in several countries around the world and so did the incidence of breast cancer.
To determine whether a similar decline of hormone therapy use and breast cancer incidence occurred in Canada, Prithwish De, Ph.D., of the Canadian Cancer Society, and colleagues, analyzed data from various Canadian registries and from a national health survey for women aged 50-69 years. Specifically, the researchers looked at information on prescriptions for hormone replacement therapy, breast cancer incidence, mammography rates, and self-reported use of hormone replacement therapy.
The researchers found that "the nearly 10% drop in invasive breast cancer rates coincided with the decline in use of hormone replacement therapy reported among Canadian women aged 50-69 years." The steepest decline in use occurred between 2002 and 2004, when use dropped from 12.7% to 4.9%. In that same period, breast cancer incidence dropped 9.6% but mammography rates remained stable.
The researchers write that the decline in breast cancer incidence "is likely explained by the concurrent decline in the use of hormone replacement therapy among Canadian women." They also say the drop in hormone therapy use may be partly explained by the media's coverage of results of both the WHI and the Million Women Study in the U.K., both of which showed that breast cancer risk was elevated with the use of combined hormone therapy. In Canada, cancer rates began to increase again in 2005 among women aged 50-69 years, which might be further evidence of a link between hormone therapy and breast cancer, according to the authors.
"Such a rebound might be expected if occult hormone-sensitive tumors were merely slowed by the withdrawal of hormone replacement therapy rather than prevented by it. If so, hormone replacement therapy may be thought to act as a promoter, rather than a cause of breast cancer," they write.
The study's limitations include the fact that data on hormone replacement therapy use was self-reported—and therefore subject to recall bias—and that data on frequency or duration of use were not collected. Also, data on receptor status of breast tumors were not collected.
In conclusion, the authors write that "further long-term surveillance studies of trends between hormone replacement therapy and breast cancer incidence can help reconcile the potential population-level associations of these two factors."
INFORMATION:
Contact:
Alexa Giorgi, Canadian Cancer Society, 1-416-934-5681, agiorgi@cancer.ca
Declining breast cancer incidence in Canada with declining HRT usage
2010-09-24
ELSE PRESS RELEASES FROM THIS DATE:
New findings on multiple sclerosis -- immune cells also attack neurons directly
2010-09-24
Researchers in Germany have gained new insight into how the immune system causes damage associated with multiple sclerosis (MS), an incurable neuroinflammatory disorder. Using imaging tools which enable investigation of processes in living organisms, they were able to show a direct interaction between immune cells and neurons which plays a significant role in neuronal injury. However, this direct interaction may respond to therapeutic intervention. The study by Dr. Volker Siffrin and Professor Dr. Frauke Zipp (formerly Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch, ...
Divisive primaries help challengers and hurt incumbents
2010-09-24
Los Angeles, CA (Sept 23, 2010) Divisive primaries may waste precious campaign resources and damage the primary winner's reputation and chances to win the general election, according to a study in the current American Politics Research (published by SAGE). The timing of the primary in proximity to the general election can also play a role in the results.
To test the effects of divisive primary battles on general election outcomes, researchers gathered primary and general election vote data for all incumbent House races between 1972 and 1998 in which both parties held ...
UCLA cancer researchers discover new signaling pathway that controls cell development and cancer
2010-09-24
Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered a new cell signaling pathway that controls cell growth and development, a pathway that, when defective, helps promote the formation of several major forms of human cancer, including lymphoma and leukemia.
The new pathway, part of a global DNA damage response, turns off 136 genes, including some that have are known to cause cancer because, unchecked, they can promote aberrant cell division.
"It's important to make sure this pathway works correctly, because it prevents cells from dividing excessively" ...
Magnetic power offers energy-saving alternative
2010-09-24
The Office of Naval Research Global (ONR Global) continues to pursue aggressive energy goals established by Secretary of the Navy Ray Mabus, with the design of a system that controls electrical flow for lighting, a highly efficient platform that may spark a new era of power savings.
Designed by the Tokyo Institute of Technology and fine-tuned by researchers at MERSTech in partnership with the ONR Global's office in Tokyo, the Magnetic Energy Recovery Switch (MERS) harnesses and recycles residual magnetic power that is produced by electrical current. By using a device ...
A drug against AIDS could be effective against the herpes virus
2010-09-24
Scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by the coordinator of the Structural and Computational Biology Programme, Miquel Coll, have published a new study that demonstrates that raltegravir, the drug approved in 2007 for the treatment of AIDS that is sold by Merck under the name Isentress, cancels the function of an essential protein for the replication of one kind of herpes virus. This study, published in the journal Proceedings of the National Academy of Sciences (PNAS), is the first step towards the development of a drug against ...
Study reveals stress hormone impacts on alcohol recovery
2010-09-24
Scientists at the University of Liverpool have found that high levels of a stress hormone in recovering alcoholics could increase the risk of relapse.
The study showed that cortisol, a hormone produced by the adrenal gland in response to stress, is found in high levels in chronic alcoholics, as well as those recovering from the condition. Researchers found that this could result in impaired memory, attention and decision-making functions, which could decrease the patient's ability to engage with treatment.
Chronic alcoholism is a disabling addictive disorder, characterised ...
Psychotropic medication and youth in foster care report
2010-09-24
Boston, MA -
The Tufts Clinical and Translational Science Institute (CTSI) today issued a landmark report from a multi-state study on psychotropic medication oversight in foster care. Led by Laurel K. Leslie, MD, MPH at Tufts CTSI, Christopher Bellonci, MD at Tufts Medical Center and Justeen Hyde, PhD at Cambridge Health Alliance, the study examined state policies and practices in 47 states, including Massachusetts, and the District of Columbia regarding the use of medication for treating behavioral and mental health problems in foster care children and adolescents ages ...
Anger amplifies clinical pain in women with and without fibromyalgia
2010-09-24
Researchers from Utrecht University who studied the effect of negative emotions on pain perception in women with and without fibromyalgia found that anger and sadness amplified pain equally in both groups. Full findings are now online and will publish in the October print issue of Arthritis Care & Research, a journal of the American College of Rheumatology.
Fibromyalgia (FM), a chronic pain condition, has among the largest impact of all rheumatic and chronic pain conditions. In addition to chronic, widespread pain, patients report accompanying symptoms such as fatigue, ...
City living helped humans evolve immunity to TB
2010-09-24
New research has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.
The research, published in the journal Evolution, shows that in areas with a long history of urban settlements, today's inhabitants are more likely to possess the genetic variant which provides resistance to infection.
In ancient cities, poor sanitation and high population densities would have provided an ideal breeding ground for the spread of disease. Natural selection ...
New map offers a global view of health-sapping air pollution
2010-09-24
In many developing countries, the absence of surface-based air pollution sensors makes it difficult, and in some cases impossible, to get even a rough estimate of the abundance of a subcategory of airborne particles that epidemiologists suspect contributes to millions of premature deaths each year. The problematic particles, called fine particulate matter (PM2.5), are 2.5 micrometers or less in diameter, about a tenth the fraction of human hair. These small particles can get past the body's normal defenses and penetrate deep into the lungs.
To fill in these gaps in surface-based ...